Aclarion, Inc. (ACONW) stock

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30

$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Aclarion EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

Aclarion's EPS for the twelve months ending Sep 30, 2025 was -$1686.13. For fiscal 2025 it was -$13.61. The highest annual figure on record is -$13.61 in fiscal 2025.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$13.61	–
FY2024	Dec 31, 2024	-$7478.90	–
FY2023	Dec 31, 2023	-$79782.00	–
FY2022	Dec 31, 2022	-$177411.67	–
FY2021	Dec 31, 2021	-$952468.16	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$1.12	–
Q1 FY2026	Mar 31, 2026	-$1.34	–
Q3 FY2025	Sep 30, 2025	-$2.93	–
Q2 FY2025	Jun 30, 2025	-$2.75	–
Q1 FY2025	Mar 31, 2025	-$9.32	–
Q4 FY2024	Dec 31, 2024	-$1671.13	–
Q3 FY2024	Sep 30, 2024	-$1321.49	–
Q2 FY2024	Jun 30, 2024	-$1362.83	–
Q1 FY2024	Mar 31, 2024	-$3985.22	–
Q4 FY2023	Dec 31, 2023	-$16433.08	–
Q3 FY2023	Sep 30, 2023	-$16917.89	–
Q2 FY2023	Jun 30, 2023	-$25603.01	–
Q1 FY2023	Mar 31, 2023	-$21622.33	–
Q4 FY2022	Dec 31, 2022	-$17492.78	–
Q3 FY2022	Sep 30, 2022	-$28950.40	–
Q4 FY2021	Dec 31, 2021	-$217199.33	–
Q3 FY2021	Sep 30, 2021	-$518212.16	–